AbbVie Inc. AstraZeneca plc
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co. Inc
Novartis AG
Pfizer Inc. Sanofi S.A. and Takeda Pharmaceutical Company Limited
Published | Pages | Publisher | Report code |
---|---|---|---|
Nov 2023 | 148 | iMarc Group | ASDR-640193 |
AbbVie Inc. AstraZeneca plc
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co. Inc
Novartis AG
Pfizer Inc. Sanofi S.A. and Takeda Pharmaceutical Company Limited